A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)
Status:
Completed
Trial end date:
2022-01-25
Target enrollment:
Participant gender:
Summary
This is a randomised, double-masked, parallel group, multicentre study to evaluate the
efficacy and safety of QL1207 compared to Eylea® in subjects with wet AMD.